Medicare Enrolled
Dr. Anne Cummings, M.D.
Internal Medicine · Greenbrae, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cummings from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cummings?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cummings
Dr. Anne Cummings is an internal medicine specialist in Greenbrae, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cummings performed 7,649 Medicare services across 2,278 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cummings received a total of $3,138 from 27 pharmaceutical and/or device companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cummings is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 3% volume in CA
$3,138 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,649
Medicare services
Top 3% in CA for internal medicine
2,278
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~403 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 3,000 | $18 | $42 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
689 | $46 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
659 | $113 | $193 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
655 | $48 | $60 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
493 | $44 | $150 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
246 | $103 | $130 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
197 | $78 | $132 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
173 | $156 | $211 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
172 | $13 | $60 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
135 | $38 | $100 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
126 | $72 | $135 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
126 | $35 | $35 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
123 | $13 | $60 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
123 | $1 | $5 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
107 | $48 | $100 |
| Annual depression screening | 102 | $21 | $28 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
86 | $53 | $120 |
| COVID-19 vaccine administration Administration of a single dose of the coronavirus vaccine. |
68 | $50 | $75 |
| COVID-19 vaccine (Moderna bivalent) An intramuscular injection of the SARS-CoV-2 vaccine containing 50 micrograms in a 0.5 mL dose. |
67 | $143 | $220 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
58 | $26 | $50 |
| Adm sarscv2 bvl 50mcg/.5ml a | 46 | $50 | $150 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $161 | $259 |
| COVID-19 mRNA vaccine booster injection Intramuscular injection of a 30 mcg booster dose of the mRNA-based COVID-19 vaccine. The vaccine is preservative-free and reconstituted with diluent prior to administration. |
43 | $50 | $150 |
| Ear wax removal A procedure to remove impacted ear wax from the ear canal. |
43 | $43 | $80 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
26 | $10 | $25 |
| Respiratory virus nucleic acid test, 3-5 targets A laboratory test that uses nucleic acid detection to identify multiple types or subtypes of respiratory viruses. The test analyzes 3 to 5 specific viral targets. |
24 | $140 | $500 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
16 | $117 | $220 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,138
Total received (2018-2024)
Avg $448/year across 7 years
Top 21% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
141
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,113 (99.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$25 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$369
2023
$638
2022
$330
2021
$586
2020
$601
2019
$327
2018
$288
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$250
Lilly USA, LLC
$28
Radius Health, Inc.
$27
Azurity Pharmaceuticals, Inc.
$25
Astellas Pharma US Inc
$21
Amgen Inc.
$18
Top 3 companies account for 82.7% of 2024 payments
All-time payments by company (2018-2024) ›
Radius Health, Inc.
$487
Amgen Inc.
$472
Novo Nordisk Inc
$393
Astellas Pharma US Inc
$279
ARBOR PHARMACEUTICALS, INC.
$249
Lilly USA, LLC
$207
Edwards Lifesciences Corporation
$204
AbbVie Inc.
$152
Merck Sharp & Dohme LLC
$110
Merck Sharp & Dohme Corporation
$83
Arbor Pharmaceuticals, Inc.
$75
ABBVIE INC.
$64
Eisai Inc.
$42
IBSA Pharma Inc.
$37
AstraZeneca Pharmaceuticals LP
$37
GlaxoSmithKline, LLC.
$27
Azurity Pharmaceuticals, Inc.
$25
Sanofi Pasteur Inc.
$25
Biohaven Pharmaceutical Holding Company Ltd.
$24
Bayer HealthCare Pharmaceuticals Inc.
$23
Xeris Pharmaceuticals, Inc.
$21
EISAI INC.
$20
PFIZER INC.
$18
Galderma Laboratories, L.P.
$18
Alkermes, Inc.
$17
Takeda Pharmaceuticals U.S.A., Inc.
$15
Allergan Inc.
$12
Top 3 companies account for 43.1% of all-time payments
Associated products mentioned in payments ›
AMYVID · Aimovig · BELSOMRA · BREO · BYSTOLIC · Dayvigo · EDARBI · EMGALITY · EVENITY · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · GVOKE HYPOPEN · Horizant · Kerendia · LICART · MOUNJARO · MYRBETRIQ · NO PRODUCT DISCUSSED · NURTEC ODT · Ozempic · Prolia · QULIPTA · Repatha · Rybelsus · SHINGRIX · SYNTHROID · TAGRISSO · Tirosint · Trintellix · Tymlos · UBRELVY · VRAYLAR · Veozah · Vivitrol · Wegovy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
2,144
Per 100K population
828.6
County median income
$142,785
Nearest hospital
MARINHEALTH MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cummings is a clinical cardiology specialist, with above-average Medicare volume (top 3% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cummings experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Cummings performed 3,000 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cummings receive payments from pharmaceutical companies?
Yes. Dr. Cummings received a total of $3,138 from 27 companies across 141 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cummings's costs compare to other internal medicine physicians in Greenbrae?
Dr. Cummings's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cummings) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Greenbrae
Browse internal medicine physicians in Greenbrae ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Radius Health, Inc. Payments to Doctors
See all physicians who received payments from Radius Health, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology